<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02520986</url>
  </required_header>
  <id_info>
    <org_study_id>CONDYLOMA-1</org_study_id>
    <nct_id>NCT02520986</nct_id>
  </id_info>
  <brief_title>Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma</brief_title>
  <official_title>Carbon Dioxide Laser Ablation Versus Electrocoagulation - a Prospective, Randomized Multicenter Trial Comparing Two Surgical Treatments in Women Undergoing Therapy for Condyloma Acuminata</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zydolab - Institute of Cytology and Immune Cytochemistry</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ruhr University of Bochum</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zydolab - Institute of Cytology and Immune Cytochemistry</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a randomized clinical trial of 114 women undergoing Treatment for condyloma acuminata, two
      surgical methods, the carbon dioxide laser Ablation and the excision by electrocoagulation,
      will be compared. The primary outcome of the study is the cosmetic result judged by the
      Patient 6 weeks after Treatment using a 11-step visual analogue scale (VAS), secondary
      outcomes are intervention time, operative complications, subjects and users satisfaction,
      postoperative pain and recurrence of genital warts.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cosmetic result</measure>
    <time_frame>6 weeks</time_frame>
    <description>Cosmetic result judged by the Patient 6 weeks after Treatment using a 11-step visual analogue scale (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>users satisfaction</measure>
    <time_frame>30 minutes</time_frame>
    <description>surgeons will score their satisfaction concerning the used technique by using a 11-step visual analogue scale (VAS) within 30 minutes after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation time</measure>
    <time_frame>20 minutes</time_frame>
    <description>the time from the beginning of the Treatment until the end of the operation (the end of hemostatic interventions) will be measured in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>5 hours</time_frame>
    <description>patients will score their postoperative pain Level using a 11-step visual analogue scale (VAS) within 5 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects satisfaction</measure>
    <time_frame>6 weeks</time_frame>
    <description>Patients will score their Overall satisfaction by using a 11-step visual analogue scale (VAS) 6 weeks after Treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of genital warts</measure>
    <time_frame>12 months</time_frame>
    <description>an examination will be performed 12 months after surgery; Recurrence of genital warts will be determined if one or more Areas are infected by genital warts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative complications</measure>
    <time_frame>14 days</time_frame>
    <description>Operative complications defined as necessity to intervene surgically up to 14 days postoperatively (number of patients with operative complications and type of complication)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects satisfaction</measure>
    <time_frame>12 weeks</time_frame>
    <description>Patients will score their Overall satisfaction by using a 11-step visual analogue scale (VAS) 12 weeks after Treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic result</measure>
    <time_frame>12 weeks</time_frame>
    <description>Cosmetic result judged by the Patient 12 weeks after Treatment using a 11-step visual analogue scale (VAS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">114</enrollment>
  <condition>Condylomata Acuminata</condition>
  <arm_group>
    <arm_group_label>Carbon dioxide Laser ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Excision of genital warts using a carbon dioxide laser, ie CO2 Laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrocoagulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Excision of genital warts using a superficial electrical coagulation mode, ie spray coagulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Carbon dioxide Laser ablation</intervention_name>
    <description>surgical Instrument to achieve excision of genital warts by a pulsed laser of 15 Watt voltage</description>
    <arm_group_label>Carbon dioxide Laser ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrocoagulation</intervention_name>
    <description>surgical Instrument to achieve excision of genital warts by a deep tissue electrocoagulation of 80 Watt voltage</description>
    <arm_group_label>Electrocoagulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent

          -  women with anogenital affection of condyloma acuminata

        Exclusion Criteria:

          -  significant language barrier

          -  pregnancy

          -  unwillingness to participate

          -  the use of blood thinner or known coagulation disorder

          -  the use of immunosuppressive medicament

          -  HIV-Infection

          -  malignant diseases

          -  local therapy within 8 weeks before Treatment

          -  wound healing disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziad Hilal, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zydolab - Institute of Cytology and Immune Cytochemistry</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ziad Hilal, Dr. med.</last_name>
    <phone>+49231529747</phone>
    <email>z.hilal@zydolab.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology of the Ruhr University Bochum</name>
      <address>
        <city>Herne</city>
        <state>NRW</state>
        <zip>44625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clemens Tempfer, M.D.</last_name>
      <phone>02323 499 1801</phone>
      <email>Clemens.Tempfer@elisabethgruppe.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2015</study_first_submitted>
  <study_first_submitted_qc>August 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2015</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zydolab - Institute of Cytology and Immune Cytochemistry</investigator_affiliation>
    <investigator_full_name>Dr. med. Ziad Hilal</investigator_full_name>
    <investigator_title>Dr. med. Ziad Hilal</investigator_title>
  </responsible_party>
  <keyword>Sexually transmitted disease</keyword>
  <keyword>Genital Warts</keyword>
  <keyword>Venereal Warts</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Condylomata Acuminata</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

